Copyright
©2011 Baishideng Publishing Group Co.
World J Diabetes. Dec 15, 2011; 2(12): 217-220
Published online Dec 15, 2011. doi: 10.4239/wjd.v2.i12.217
Published online Dec 15, 2011. doi: 10.4239/wjd.v2.i12.217
Table 1 Effect of treatment with proton pump inhibitors on glycemic control (HbA1c) in patients with type 2 diabetes
| Total | Insulin | Metformin | Sulfonylurea | Others antidiabetic drugs | |
| Without PPI | |||||
| HbA1C (%) | 7.3 | 7.6 | 7.4 | 7.2 | 8.0 |
| SD (%) | 1.4 | 1.5 | 1.6 | 1.1 | 1.2 |
| n | 43 | 19 | 24 | 11 | 4 |
| With PPI | |||||
| HbA1C (%) | 6.7 | 6.8 | 6.7 | 6.7 | 7.2 |
| SD (%) | 1.0 | 0.8 | 1.0 | 0.7 | 1.2 |
| n | 54 | 28 | 23 | 10 | 13 |
| Absolute difference | -0.6 | -0.8 | -0.7 | -0.5 | -0.8 |
| P value | 0.018 | 0.022 | NS | NS | NS |
- Citation: Boj-Carceller D, Bocos-Terraz P, Moreno-Vernis M, Sanz-Paris A, Trincado-Aznar P, Albero-Gamboa R. Are proton pump inhibitors a new antidiabetic drug? A cross sectional study. World J Diabetes 2011; 2(12): 217-220
- URL: https://www.wjgnet.com/1948-9358/full/v2/i12/217.htm
- DOI: https://dx.doi.org/10.4239/wjd.v2.i12.217